US Glioma Diagnosis Treatment Market: How Is Temozolomide and the Stupp Protocol Defining Standard Care?
Temozolomide and the Stupp protocol — the concurrent temozolomide (TMZ) chemoradiation followed by adjuvant TMZ chemotherapy representing the standard of care for newly diagnosed GBM since the landmark 2005 Stupp NEJM trial — creates the foundational treatment market, with the US Glioma Diagnosis Treatment Market reflecting standard chemoradiation as the commercial and clinical...
0 Комментарии 0 Поделились 10 Просмотры 0 предпросмотр